Collaboration - June 12, 2017
Bonebank to establish German-Danish biobank
BONEBANK will establish a German-Danish biobank for stem cells in bone healing. The project partners from Germany and Denmark work together I) to develop a procedure for harvesting bone stem cells in the clinical treatment of bone healing during routine operations, II) to build a German-Danish biobank for stem cells located in Lübeck and Odense, […]
Agreement - May 8, 2017
NNIT, Novo Nordisk renew agreement
NNIT has signed an extension of its infrastructure outsourcing agreement with Novo Nordisk. The estimated total value of the agreement amounts to approximately DKK 1bn and covers global services, including support and maintenance of Novo Nordisk’s corporate IT infrastructure. The agreement covers Novo Nordisk’s global IT infrastructure and further supports the pharmaceutical company’s cloud strategy […]
Agreement - May 2, 2017
Lundbeck in conditional agreement and divests part of its headquarters
H. Lundbeck has signed a conditional agreement regarding the sale of properties (approximately 33,000 m2) on the Valby site in Copenhagen to the Danish pension funds Juristernes og Økonomernes Pensionskasse (JØP) and Danske civil- og akademiingeniørers Pensionskasse (DIP). Provided that the pre-specified conditions are met, Lundbeck will receive a cash payment of DKK 378 million […]
Global report - April 24, 2017
Astellas gathers all corporate support functions to Denmark
The global pharmaceutical company Astellas has gathered all corporate support functions to its Nordic and Baltic sales units in Denmark. “In Stockholm, 90 percent of our employees would be Swedish, in Oslo they would be Norwegian, and in Finland they would be Finns. But in Copenhagen, we have employees with four Nordic nationalities, with a […]
Uncategorized - April 21, 2017
Five new super hospitals underway in Denmark
The construction of five new national super hospitals with health IT infrastructure is now well underway in Denmark, reports Invest in Denmark. Danish hospitals have been co-developing innovative healthcare solutions with the industry for many years. This approach is now extended to a core methodology in a so-called intelligent hospital construction. 5 new national super […]
Clinical Trials - April 4, 2017
Ascendis Pharma presents new data
Ascendis Pharma has announced data supporting its product pipeline presented at ENDO 2017, the annual meeting of the Endocrine Society in Orlando, Florida. “We are delighted to show the breadth of our growing pipeline at this year’s ENDO conference, including three potentially differentiated treatments for rare endocrine diseases,” said Jonathan Leff, M.D., Chief Medical Officer […]
